Impact of Menstruation on Glycemic Response and Exercise in Females With Type 1 Diabetes
This study is looking at how your menstrual cycle and hormonal birth control might affect your blood sugar (glycemic control) if you have Type 1 Diabetes. Researchers will observe your glucose patterns using continuous glucose monitoring (CGM) for three months to see how your blood sugar changes during different phases of your cycle and with exercise. Then, they will test personalized adjustments to your insulin doses (basal or bolus rates) and carbohydrate ratios to help manage these changes. The goal is to improve your blood sugar control throughout your menstrual cycle. We are looking for women aged 18 to 45 who have had Type 1 Diabetes for at least 12 months and have regular menstrual cycles or use oral contraceptives. Success will be measured by how much time your blood sugar stays within a healthy range and how stable your blood sugar levels are after three months of the intervention. The current recruitment status is unclear.
- Study design
- This is an interventional study planning to enroll 150 women. It involves an observational period followed by personalized adjustments to treatment.
- What's involved
- You would participate in a three-month observational period where your glucose patterns are monitored. This is followed by personalized changes to your insulin and food intake.
- Compensation
- Not stated in the trial record.
- Follow-up
- Glucose time in range and standard deviation will be measured at 3 months during randomization to intervention or standard care.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Impact of MEnstruation on Glycemic Response and Exercise In Females With Type 1 Diabetes
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- JANET K SNELL-BERGEON, PhD, MPH · PRINCIPAL_INVESTIGATOR · University of Colorado, Denver
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Glucose time in range3 months during randomization to intervention or standard care
time spent with glucose 70-180mg/dL on continuous glucose monitor
- Glucose standard deviation3 months during randomization to intervention or standard care
standard deviation (mg/dL) of glucose on continuous glucose monitor